November’s General Meeting speaker is Carolyn Rodriguez, MD, PhD at Stanford. She will discuss OCD treatment advances. Standard first-line treatments for OCD may not provide sufficient relief of OCD symptoms for all those seeking care; thus, there is an urgent need for alternative treatments. Dr. Rodriguez will summarize her recent work in novel medication, therapy and other treatments for those considering future treatment options.
The format will be an interactive presentation followed by Q&A.
Carolyn Rodriguez, MD, PhD is Assistant Professor of Psychiatry at Stanford University and Director of the Stanford Translational OCD Research Program. Her lab utilizes an inter- disciplinary approach to gain understanding of OCD at multiple levels (from molecule to circuits to behavior) to develop novel treatments.
Dr. Rodriguez is Vice Chair of the annual IOCDF Research Symposium, Vice Chairperson of the Council of Research of the American Psychiatric Association, and recipient of the 2017 Eva King-Killam Research Award for outstanding translational research contributions.
Please join us at 7 P.M. in the auditorium of Good Samaritan Hospital (main building basement).
At 7:15 we will have NAMI announcements, followed by our speaker from 7:30–8:30. (Good Samaritan is located at 2425 Samaritan Dr., San Jose. Find directions at www.maps.yahoo.com)
Upcoming General Meeting Speakers
Jan. 8, 2019: Steven Sust, MD
Working with SCC Emergency Psychiatric Services (EPS)
Feb. 12, 2019: Ricque Brister, MD
The Seven Dwarfs and Brain Chemistry